| # | Drug | Count |
|---|---|---|
| 0 | FINGOLIMOD HCL | 88 |
| 1 | PREDNISONE | 80 |
| 2 | TACROLIMUS | 76 |
| 3 | CYCLOPHOSPHAMIDE | 63 |
| 4 | CYCLOPHOSPHAMIDE FOR INJECTION | 63 |
| 5 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 63 |
| 6 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 61 |
| 7 | TACROLIMUS OINTMENT 0.1% | 61 |
| 8 | MYCOPHENOLATE MOFETIL | 59 |
| 9 | MYCOPHENOLATE MOFETIL HYDROCHLORIDE | 59 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | SUMATRIPTAN AND NAPROXEN SODIUM | 1 | 0.0455 |
| 1 | VORETIGENE NEPARVOVEC-RZYL | 3 | 0.0197 |
| 2 | DINUTUXIMAB | 8 | 0.0093 |
| 3 | IOBENGUANE I-123 | 1 | 0.0088 |
| 4 | FOSAMPRENAVIR CALCIUM | 1 | 0.0076 |
| 5 | CHLOROQUINE PHOSPHATE | 5 | 0.0076 |
| 6 | PIMOZIDE | 3 | 0.0062 |
| 7 | SOMAPACITAN-BECO | 1 | 0.0055 |
| 8 | ETOPOSIDE PHOSPHATE | 9 | 0.0055 |
| 9 | VINBLASTINE SULFATE | 10 | 0.0051 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 209 |
| 1 | Anti-epileptic Agent [EPC] | 99 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 83 |
| 3 | Benzodiazepine [EPC] | 77 |
| 4 | Alkylating Drug [EPC] | 76 |
| 5 | Platinum-based Drug [EPC] | 73 |
| 6 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 65 |
| 7 | CD20-directed Cytolytic Antibody [EPC] | 54 |
| 8 | Atypical Antipsychotic [EPC] | 50 |
| 9 | Dihydropyridine Calcium Channel Blocker [EPC] | 48 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Glycolipid Disialoganglioside-directed Antibody [EPC] | 8 | 0.0074 |
| 1 | Actinomycin [EPC] | 11 | 0.0050 |
| 2 | Endoglycosidase [EPC] | 9 | 0.0049 |
| 3 | Osmotic Diuretic [EPC] | 13 | 0.0025 |
| 4 | Antihypoglycemic Agent [EPC] | 9 | 0.0021 |
| 5 | Lymphocyte Growth Factor [EPC] | 2 | 0.0016 |
| 6 | Nucleoside Analog Antifungal [EPC] | 2 | 0.0014 |
| 7 | Provitamin D2 Compound [EPC] | 40 | 0.0013 |
| 8 | Antimycobacterial [EPC] | 31 | 0.0013 |
| 9 | CD19-directed Cytolytic Antibody [EPC] | 1 | 0.0012 |